Toll-like receptors and hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 5, 2014, Pages

  Singh, Madhu V ^a   Abboud, François M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Hypertension; Innate immune system; MyD88; Toll like receptors

Indexed keywords

ADAPTOR PROTEIN; ANGIOTENSIN II; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR RELA;

ANGIOTENSIN II HYPERTENSION; CELL INFILTRATION; CONCEPTUAL FRAMEWORK; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INNATE IMMUNITY; KIDNEY DISEASE; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT;

HYPERTENSION; INNATE IMMUNE SYSTEM; MYD88; TOLL-LIKE RECEPTORS;

ANIMALS; CARDIOMEGALY; HUMANS; HYPERTENSION; IMMUNITY, INNATE; NF-KAPPA B; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84907353583     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00194.2014     Document Type: Review

References (35)

1. Abboud FM, Harwani SC, Chapleau MW. Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertension 59: 755-762, 2012.
2. Ahn KO, Lim SW, Li C, Yang HJ, Ghee JY, Kim JY, Kim SH, Kim J, Yang CW. Influence of angiotensin II on expression of toll-like receptor 2 and maturation of dendritic cells in chronic cyclosporine nephropathy. Transplantation 83: 938-947, 2007.
3. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263, 2004.
4. Bomfim GF, Dos Santos RA, Oliveira MA, Giachini FR, Akamine EH, Tostes RC, Fortes ZB, Webb RC, Carvalho MH. Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin Sci (Lond) 122: 535-543, 2012.
5. Botos I, Segal DM, Davies DR. The structural biology of Toll-like receptors. Structure 19: 447-459, 2011.
6. Chatterjee P, Chiasson VL, Kopriva SE, Young KJ, Chatterjee V, Jones KA, Mitchell BM. Interleukin 10 deficiency exacerbates toll-like receptor 3-induced preeclampsia-like symptoms in mice. Hypertension 58: 489-496, 2011.
7. Crowley SD, Song YS, Lin EE, Griffiths R, Kim HS, Ruiz P. Lymphocyte responses exacerbate angiotensin II-dependent hypertension. Am J Physiol Regul Integr Comp Physiol 298: R1089-R1097, 2010.
8. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27: 801-810, 2007.
9. Eissler R, Schmaderer C, Rusai K, Kuhne L, Sollinger D, Lahmer T, Witzke O, Lutz J, Heemann U, Baumann M. Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res 34: 551-558, 2011.
10. Goulopoulou S, Matsumoto T, Bomfim GF, Webb RC. Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia. Clin Sci (Lond) 123: 429-435, 2012.
11. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007.
12. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, hypertension. Hypertension 57: 132-140, 2011.
13. Harwani SC, Chapleau MW, Legge KL, Ballas ZK, Abboud FM. Neurohormonal modulation of the innate immune system is proinflammatory in the prehypertensive spontaneously hypertensive rat, a genetic model of essential hypertension. Circ Res 111: 1190-1197, 2012.
14. Ji Y, Liu J, Wang Z, Liu N. Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 23: 265-276, 2009.
15. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, Hoshino K, Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167: 5887-5894, 2001.
16. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388: 621-625, 2009.
17. Li DJ, Evans RG, Yang ZW, Song SW, Wang P, Ma XJ, Liu C, Xi T, Su DF, Shen FM. Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension. Hypertension 57: 298-307, 2011.
18. Luft FC, Dechend R, Muller DN. Immune mechanisms in angiotensin II-induced target-organ damage. Ann Med 44, Suppl 1: S49-S54, 2012.
19. Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, Iwakura Y, Blinder Y, Rahman A, Quyyumi AA, Harrison DG. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 31: 1565-1572, 2011.
20. McCarthy CG, Goulopoulou S, Wenceslau CF, Spitler K, Matsumoto T, Webb RC. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am J Physiol Heart Circ Physiol 306: H184-H196, 2014.
21. Mian MO, Paradis P, Schiffrin EL. Innate immunity in hypertension. Current Hypertens Reports 16: 413, 2014.
22. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Rev Immunol 7: 353-364, 2007.
23. Rodríguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor- B prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exptl Ther 315: 51-57, 2005.
24. Rodriguez-Iturbe B, Pons H, Quiroz Y, Lanaspa MA, Johnson RJ. Autoimmunity in the pathogenesis of hypertension. Nature Rev Nephrol 10: 56-62, 2014.
25. Rodriguez-Iturbe B, Quiroz Y, Ferrebuz A, Parra G, Vaziri ND. Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats. Am J Nephrol 24: 587-594, 2004.
26. Ryan MJ. Does interleukin 6 contribute to renal hemodynamic changes during angiotensin II-dependent hypertension? Hypertension 56: 819-821, 2010.
27. Ryan MJ. An update on immune system activation in the pathogenesis of hypertension. Hypertension 62: 226-230, 2013.
28. Singh M, Chapleau M, Harwani S, Abboud F, The immune system and hypertension. Immunol Res, 2014, May 22.
29. Singh MV, Cicha MZ, Chapleau MW, Abboud FM. Selective pathways of innate immune responses of heart and kidney during angiotensin II hypertension. In: Experimental Biology 2014. San Diego, CA: 2014, p. A54-A857.
30. Singh MV, Swaminathan PD, Luczak ED, Kutschke W, Weiss RM, Anderson ME. MyD88 mediated inflammatory signaling leads to CaM- KII oxidation, cardiac hypertrophy and death after myocardial infarction. J Mol Cell Cardiol 52: 1135-1144, 2012.
31. Smith KD. Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertensi 18: 189-196, 2009.
32. Tinsley JH, Chiasson VL, Mahajan A, Young KJ, Mitchell BM. Toll-like receptor 3 activation during pregnancy elicits preeclampsia-like symptoms in rats. Am J Hypertens 22: 1314-1319, 2009.
33. Ve T, Gay NJ, Mansell A, Kobe B, Kellie S. Adaptors in toll-like receptor signaling and their potential as therapeutic targets. Curr Drug Targets 13: 1360-1374, 2012.
34. Watters TM, Kenny EF, O'Neill LA. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol Cell Biol 85: 411-419, 2007.
35. Zubcevic J, Waki H, Raizada MK, Paton JF. Autonomic-immune- vascular interaction: an emerging concept for neurogenic hypertension. Hypertension 57: 1026-1033, 2011.